Skip to main content

13 Result(s)

within C Perot Remove this filter Cancer Research Remove this filter

and

  1. No Access

    Article

    RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation

    Myeloproliferative neoplasms are frequently associated with aberrant constitutive tyrosine kinase (TK) activity resulting from chimaeric fusion genes or point mutations such as BCR-ABL1 or JAK2 V617F. We report h...

    P Ballerini, S Struski, C Cresson, N Prade, S Toujani, C Deswarte… in Leukemia (2012)

  2. No Access

    Article

    Interest of the association azacitidine–lenalidomide as frontline therapy in high-risk myelodysplasia or acute myeloid leukemia with complex karyotype

    E Scherman, S Malak, C Perot, N C Gorin, M T Rubio, F Isnard in Leukemia (2012)

  3. No Access

    Article

    Extensive mutational status of genes and clinical outcome in pediatric acute myeloid leukemia

    H Lapillonne, L Llopis, A Auvrignon, A Renneville, M Labopin, F Mazingue… in Leukemia (2010)

  4. No Access

    Article

    Genome profiling of acute myelomonocytic leukemia: alteration of the MYB locus in MYST3-linked cases

    The t(8;16)(p11;p13) is a rare translocation involved in de novo and therapy-related myelomonocytic and monocytic acute leukemia. It fuses two genes encoding histone acetyltransferases (HATs), MYST3 located at 8p...

    A Murati, C Gervais, N Carbuccia, P Finetti, N Cervera, J Adélaïde, S Struski… in Leukemia (2009)

  5. No Access

    Article

    NCOA3, a new fusion partner for MOZ/MYST3 in M5 acute myeloid leukemia

    S Esteyries, C Perot, J Adelaide, M Imbert, A Lagarde, C Pautas, S Olschwang… in Leukemia (2008)

  6. No Access

    Article

    Hyperdiploid karyotypes in acute myeloid leukemia define a novel entity: a study of 38 patients from the Groupe Francophone de Cytogenetique Hematologique (GFCH)

    A series of 38 patients with acute myeloblastic leukemia (AML) with 49 or more chromosomes and without structural abnormalities was selected within the Groupe Francophone de Cytogénétique Hématologique (GFCH) ...

    I Luquet, J L Laï, C Barin, L Baranger, C Bilhou-Nabera, E Lippert, C Gervais… in Leukemia (2008)

  7. No Access

    Article

    Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCRβ-HOXA rearrangement: a study of the Groupe Francophone de Cytogénétique Hématologique

    Recently, we and others described a new chromosomal rearrangement, that is, inv(7)(p15q34) and t(7;7)(p15;q34) involving the T-cell receptor beta (TCRβ) (7q34) and the HOXA gene locus (7p15) in 5% of T-cell acute...

    B Cauwelier, H Cavé, C Gervais, M Lessard, C Barin, C Perot, J Van den Akker… in Leukemia (2007)

  8. No Access

    Article

    NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogénétique Hématologique

    The NUP98 gene is fused with 19 different partner genes in various human hematopoietic malignancies. In order to gain additional clinico-hematological data and to identify new partners of NUP98, the Groupe Franco...

    S P Romana, I Radford-Weiss, R Ben Abdelali, C Schluth, A Petit, N Dastugue… in Leukemia (2006)

  9. No Access

    Article

    A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma

    J Adélaïde, C Pérot, V Gelsi-Boyer, C Pautas, A Murati, C Copie-Bergman… in Leukemia (2006)

  10. No Access

    Article

    PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation

    A Murati, V Gelsi-Boyer, J Adélaïde, C Perot, P Talmant, S Giraudier, L Lodé… in Leukemia (2005)

  11. No Access

    Article

    t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH)

    To accurately estimate the incidence of HOX11L2 expression, and determine the associated cytogenetic features, in T-cell acute lymphoblastic leukemia (T-ALL), the Groupe Français de Cytogénétique Hématologique...

    R Berger, N Dastugue, M Busson, J van den Akker, C Pérot, P Ballerini… in Leukemia (2003)

  12. No Access

    Article

    A novel real-time RT-PCR assay for quantification of OTT-MAL fusion transcript reliable for diagnosis of t(1;22) and minimal residual disease (MRD) detection

    P Ballerini, A Blaise, T Mercher, B Pellegrino, C Perot, J van den Akker… in Leukemia (2003)

  13. No Access

    Article

    Nineteen cases of the t(1;22)(p13;q13) acute megakaryblastic leukaemia of infants/children and a review of 39 cases: report from a t(1;22) study group

    J Bernstein, N Dastugue, OA Haas, J Harbott, NA Heere ma, JL Huret… in Leukemia (2000)